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Abstract
Meta-analyses are increasingly popular. It is unknown whether this popularity is driven by specific countries and specific
meta-analyses types. PubMed was used to identify meta-analyses since 1995 (last update 9/1/2012) and catalogue their
types and country of origin. We focused more on meta-analyses from China (the current top producer of meta-analyses)
versus the USA (top producer until recently). The annual number of meta-analyses from China increased 40-fold between
2003 and 2011 versus 2.4-fold for the USA. The growth of Chinese meta-analyses was driven by genetics (110-fold increase
in 2011 versus 2003). The HuGE Navigator identified 612 meta-analyses of genetic association studies published in 2012
from China versus only 109 from the USA. We compared in-depth 50 genetic association meta-analyses from China versus
50 from USA in 2012. Meta-analyses from China almost always used only literature-based data (92%), and focused on one or
two genes (94%) and variants (78%) identified with candidate gene approaches (88%), while many USA meta-analyses used
genome-wide approaches and raw data. Both groups usually concluded favorably for the presence of genetic associations
(80% versus 74%), but nominal significance (P,0.05) typically sufficed in the China group. Meta-analyses from China
typically neglected genome-wide data, and often included candidate gene studies published in Chinese-language journals.
Overall, there is an impressive rise of meta-analyses from China, particularly on genetic associations. Since most claimed
candidate gene associations are likely false-positives, there is an urgent global need to incorporate genome-wide data and
state-of-the art statistical inferences to avoid a flood of false-positive genetic meta-analyses.
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Introduction
Meta-analyses are influential publications [1]. They can
summarize evidence quantitatively across diverse disciplines and
can inform decisions about the need for further research and/or
practical implementations of the research findings [2]. The
method’s popularity has surged in the last two decades with the
advent of evidence-based medicine. Noticeably, the application of
meta-analyses has extended globally, involving many other
countries beyond the United States (US) and selected western
countries. This trend reflects the globalization of scientific
research, the deluge of published data in the current era, and
the need for knowledge integration [3,4]. Given the influence of
meta-analyses in assessing the robustness of scientific evidence,
there is a need to evaluate the volume of meta-analyses and their
quality, specifically in the scientific fields which have undergone
the most rapid expansion in production of data.
To obtain a better understanding of the expansion of the meta-
analyses literature, in this paper we systematically mapped and
evaluated the extent and pace of growth of the meta-analysis
literature in biomedical science worldwide. The number of meta-
analyses published annually approximately doubled in the last 5
years. We were intrigued to document a very rapid rise in the
production of meta-analysis from China. Meta-analyses from the
US (traditionally the key producer of meta-analyses in the past) less
than doubled in the last 5 years. Conversely, meta-analyses from
China outnumber those from the US in the current production,
while very few meta-analyses came from China until a few years
ago. The advent of Chinese meta-analysis production was driven
primarily from genetics, a field that until recently was dominated
by papers from the US and a few European countries. To
understand the dynamics and patterns of this growing literature,
we also performed a more in-depth evaluation of meta-analyses of
genetic associations from China and the US to compare their
methodologic characteristics.
Methods
Survey of Meta-analyses – Search Strategies
We searched PubMed (last search date September 1, 2012) for
publications classified as type ‘‘meta-analysis’’ and performed also
counts per publication year from 1995 until 2012. We generated
separate counts for all meta-analyses worldwide, as well as those
with listed affiliation from the People’s Republic of China (China
[affiliation] NOT Taiwan [affiliation]) and, for comparison, those
with affiliation from the US (USA [affiliation] OR US [affiliation]
OR United States [affiliation]), since US has historically been the
top producer of meta-analysis publications.
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We then separated the meta-analysis publications according to
field as follows. First, genetics-related meta-analyses were searched
using the strategy ‘‘gene OR genetic OR polymorphism OR
genome OR mutation OR haplotype’’. Of those meta-analyses not
captured with this strategy, we used the search ‘‘trial OR random*
OR treatment’’ to identify treatment-related meta-analyses. Of
those captured with neither of these two strategies, we used the
search term ‘‘sensitivity’’ to identify meta-analyses of diagnostic
performance. Of those not captured with any of these three
searches, we used the search ‘‘cohort or case control’’ to identify
other meta-analyses mentioning studies with such designs. All
remaining meta-analyses were placed in a miscellaneous group.
Given that the greatest share of meta-analyses from China was
identified in the genetics-related group, we also mapped the
evolution of the number of meta-analyses in genetics (total, from
China and from US for comparison). We also evaluated whether
genetics-related meta-analyses from China are published in the
English or Chinese language, as well as whether they address
genetic associations of gene variants or other research gene-related
questions.
The HuGE Navigator [5] (last update search performed
January 13, 2013) was also used to map annually the evolution
of the number of published meta-analyses on genetic associations
of gene variants since 2000 around the world and the number of
meta-analyses published per year was plotted for the 10 most
prolific countries during 2000–2012.
Comparative Evaluation of Recent Meta-analyses in
Genetics
The field of genetics has experienced a paradigm transforma-
tion since 2005. Previously, most genetic studies followed a
candidate gene approach: one or a few genes and variants thereof
were chosen based on biological reasoning to test for association
with some phenotype/disease of interest. More recently, genome-
wide association studies (GWAS) have probed associations across
the whole genome and claim discoveries only after rigorous
replication and stringent criteria of multiplicity-adjusted signifi-
cance are met [6,7]. Large-scale agnostic studies have also
permitted testing previously proposed candidate gene associations.
In such evaluations the majority of associations proposed in the
candidate gene era have not been replicated [8–11].
Given the large amount of genetic meta-analyses from the US
and China, we compared genetic meta-analyses from the two
countries to describe the current state of meta-analysis approach in
the published literature. We evaluated 100 genetic association
meta-analysis articles (50 from China and 50 from the US)
published in 2012. We defined genetic association meta-analyses
to include studies that use published and/or new data on
candidate or GWAS-derived associations (newly proposed, or
further validated) of genetic variants with any outcome/phenotype
of interest. We included in this category, meta-analyses of variants
with pharmacogenetic associations, and meta-analyses of Mende-
lian randomization provided they also addressed some clinical
phenotype. We excluded meta-analyses of somatic mutations and
of gene expression data. Articles selection was done by systemat-
ically screening through the meta-analyses published in 2012 in
chronological order of PubMed indexing until we identified 50
eligible meta-analyses from each country group. For these 100
meta-analyses, we extracted the following information: journal of
publication (so as to identify subsequently also the 2011 Journal
Impact Factor from Thomson ISI); number of authors; language
of publication; disease/phenotype (cancer, cardiovascular, infec-
tious diseases, other disease, non-disease); type of data included
(literature, investigators’ own, both); inclusion of any unpublished
data other than those of the meta-analysis investigators; number of
genes assessed (1,2,3, .3); number of genetic variants assessed
(1,2,3, .3); any new associations proposed (yes/no – if no,
whether the previously proposed genes that were probed had been
derived from agnostic approaches (GWAS) (none [candidate genes
only], some, all – the GWAS Catalog constructed by National
Human Genome Research Institute (NHGRI) [12] was consulted
to identify whether any of the gene-phenotype associations had
been identified in GWAS); models used for data synthesis (fixed
effect, random effects, both); relative risks or absolute differences
reported in the abstract (relative risk, absolute difference, both,
none); largest relative risk (more deviating from 1.00 in either
direction) reported in the abstract; largest nominally statistically
significant relative risk reported in the abstract; any nominally
statistically significant results (P,0.05 or 95% confidence interval
excluding the null) reported in the abstract (yes/no); any genome-
wide statistically significant results (conventionally defined as
P,561028) reported in the abstract (yes/no); conclusion of the
abstract regarding whether there is some association or not (yes/
no); abstract suggesting differences in populations of different
ethnicity/ancestry (yes/no); abstract suggesting significant associ-
ations only with a particular inheritance model, and if so, which;
and any suggestions made in the abstract that more data are
needed (yes/no). We also evaluated whether the meta-analyses
included any data from GWAS (yes/no); whether the eligibility
criteria aimed to include data from Chinese-language studies (yes/
no); whether literature searches included Chinese biomedical
literature databases [13] or were limited to western databases such
as PubMed and EMBASE; and whether any Chinese-language
studies were indeed included in the meta-analysis calculations,
and, if so, how many. For comparison, we also assessed whether
studies in any other language besides English/Chinese were
considered eligible.
We compared the two groups using chi-square test with Yates’
correction, Fisher’s exact test, Freeman-Halton or chi-square test
adjusting for trend, and Mann-Whitney U test, as appropriate.
With n= 50 meta-analyses in each group, and assuming that 20%
of the US meta-analyses would assess candidate gene variants, we
had at least 90% power to find a significant difference at
alpha= 0.05, if the proportion of meta-analyses from China
addressing candidate genes were 50% or higher [14]. One
comparison used all 100 meta-analyses; a further analysis focused
only on meta-analyses that addressed only genetic variants that
have not been validated in GWAS, since the large majority of
these associations are likely to be spurious [8,9,10,15,16]. All P-
values are two-tailed.
Results
Number of Meta-analyses
As of September 1, 2012, PubMed tagged a total of 34,238
publications as meta-analyses. The number published each year
since 1995 is shown in Table 1. Overall, there is a substantial
growth over time, with 11-fold increase in the annual number
between 1995 and 2011. In the same time frame, the annual
volume of items indexed in PubMed has approximately doubled
(n= 443,543 in 1995, n= 865,176 in 2011).
The United States was the most common country affiliation
accounting for 8,886 of the 34,238 meta-analyses (26%). There is a
clear decline in the proportion of the total represented over time
(from 38% in 1995 down to 20% in 2012). Conversely, China has
emerged as a dominant publisher of meta-analyses. When all years
are considered, it lagged behind the US with a total of 2,587 (8%)
publications overall; nevertheless, the rate of growth in meta-
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analyses is rapid. Prior to 2003, China contributed less than 1% of
the total meta-analyses. Between 2003 and 2011, the annual
number of Chinese meta-analyses increased over 4000%, versus
140% for the US. In 2012 meta-analyses from China surpassed
meta-analyses from the US (21% versus 20% of the total).
The sheer proportional increase in the number of published
meta-analyses is markedly specific for China. Japan accounts for
1.5% of meta-analyses published (1.3% when limited to 2012
alone), and no other Asian country accounts for more than 1% of
meta-analyses published over all time or focusing on 2012 only.
Several European countries have long published meta-analyses
and continue to do so with modest increases in the number of
meta-analyses published per year, but currently their relative
contribution is far less prominent than US or China (not shown in
detail).
Types of Meta-analyses
As shown in Table 2, the majority of meta-analyses overall
pertain to clinical trials and treatment topics (68%). Genetics-
related meta-analyses accounted for 11% of the total when all
years are considered and substantially higher proportions in later
years (19% in 2012).
Among genetics-related meta-analyses, production from China
accounts for 26% of all meta-analyses when all years are
considered and approximately half of the published papers
(48%) in 2012. In 2012, among papers from China, genetics-
related meta-analyses outnumber in absolute numbers meta-
analyses of clinical trials and treatments; conversely meta-analyses
of clinical trials and treatments remain more than 5-times more
Table 1. Meta-analyses in PubMed According to Publication
Year.
Year All China US
1995 429 0 165
1996 482 1 197
1997 596 3 250
1998 639 0 235
1999 741 0 305
2000 849 2 335
2001 948 3 366
2002 1078 11 400
2003 1289 19 401
2004 1594 28 467
2005 2063 33 541
2006 2331 77 681
2007 2594 97 696
2008 2773 179 756
2009 3229 302 774
2010 3904 540 896
2011 4739 828 965
2012 (until search) 2270 464 446
US: United States. When a paper in published as Epub and then final
publication, the year of the final publication is counted. The same applies to
data in tables 2 and 3.
doi:10.1371/journal.pone.0065602.t001
Table 2. Different Types of Meta-analyses Overall and from China.
Any publication year
Published in 2012
(until September 1 search)
Search strategy All China (%) All China (%)
Gene OR genetic OR polymorphism OR genome OR mutation
OR haplotype
3631 942 (26) 441 210 (48)
Trial OR randomi* OR treatment 23529 1307 (6) 1388 195 (14)
Sensitivity 1298 125 (10) 99 24 (24)
Cohort OR case control 1151 86 (7) 62 10 (16)
Miscellaneous meta-analyses 4629 127 (3) 280 25 (9)
ALL META-ANALYSES 34238 2587 (8) 2270 464 (21)
doi:10.1371/journal.pone.0065602.t002
Table 3. Genetics-related Meta-analyses.
Year All China US
1995 12 0 6
1996 9 0 5
1997 31 1 15
1998 24 0 4
1999 40 0 13
2000 50 0 18
2001 61 0 23
2002 56 0 17
2003 91 3 22
2004 130 5 36
2005 155 9 37
2006 213 21 51
2007 245 26 56
2008 286 40 66
2009 394 81 75
2010 590 221 105
2011 774 327 137
2012 (until search) 441 210 61
US: United States.
doi:10.1371/journal.pone.0065602.t003
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common than genetics-related meta-analyses among papers
coming from countries other than China (n= 1191 versus n= 231).
Growth of Genetics-related Meta-analyses
Table 3 shows the yearly publication of genetics-related meta-
analysis from 1995 to 2012 for all countries, China, and the US.
Compared to 1995, there was a 64-fold increase in the number of
genetics-related meta-analyses in 2011. The contribution from the
US was particularly dominant from 1995 to 1997, where it
contributed approximately half of the total papers published. The
proportion of US contribution has gradually declined to 14%. The
converse is observed for China where it contributed no genetics-
related meta-analysis from 1995 to 2002. From 2003, a rapid
growth occurred with what appeared to be a doubling in the
annual number of contributions per year. More specifically
between 2003 and 2011, there was a 110-fold increase in
publications from China. In 2012 (based on papers indexed in
PubMed through August), genetics-related meta-analyses from
China were 3.5-fold more prevalent than meta-analyses from the
US (n= 210 versus n = 61).
With very few exceptions, the genetics-related meta-analyses
from China indexed in PubMed are published in English-language
journals (902/942, 96%). Following a suggestion raised during
peer-review, we assessed whether any of the meta-analyses from
China had been published in duplicate, in both the Chinese and
English language. Careful scrutiny of a sample of 15 Chinese-
language meta-analyses on genetic associations showed that for 2
of them, a corresponding meta-analysis on the same variant and
phenotype and with partially overlapping authors had been
published also in an English-language journal within ,1 year
time-difference. In one pair, the Chinese-language meta-analysis
[17] concluded that GSTM1 is significantly associated with
colorectal cancer risk, while the English-language meta-analysis
[18] concluded that GSTM1 is not significantly associated with
colorectal cancer risk, while other metabolic enzyme genetic
polymorphisms were associated. In the other pair, the Chinese-
language meta-analysis [19] found associations for SLC11A1
(formerly NRAMP1) gene polymorphisms and tuberculosis
susceptibility focusing on East Asian populations, while the
English-language meta-analysis [20] included diverse ethnic
groups and also found significant associations for the same
variants in East Asian populations but not with identical effect
sizes.
The large majority of the Chinese genetics-related meta-
analyses addressed genetic associations of gene variants (95/100
among the latest 100 meta-analyses indexed in PubMed, 90/95
evaluating only a single gene). Figure 1 shows the data from HuGE
Navigator on the ten most prolific countries of genetic association
meta-analyses with data updated to the end of 2012. Consistent
Figure 1. Annual number of meta-analyses of genetic associations for the 10 most-prolific countries in the period 2000–2012; data
are derived from HuGE Navigator (last update January 13, 2012).
doi:10.1371/journal.pone.0065602.g001
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with the PubMed data, the genetic association meta-analyses from
China followed a geometric growth, while the US slowed, and
other countries contributed comparatively few meta-analyses.
Among Asian countries, South Korea is fourth in number of
genetic association meta-analyses in 2012, but very far from both
China. By the end of 2012, there were 612 genetic association
meta-analyses published from China in that single year, versus
only 109 from the US, 49 from the United Kingdom, and 44 from
South Korea. No other country produced more than 30 genetic
association meta-analyses in 2012.
Comparative Evaluation of Genetic Association Meta-
analyses from China and US
Table 4 shows the distribution of articles published in 2012 for
China and US by selected characteristics. As shown, meta-analyses
from China and the US differed significantly in several features,
including source of data, number of genes studied, and type of
approaches (candidate-gene or GWAS). Ninety-two percent of
Chinese articles performed their meta-analyses using only data
abstracted from the literature as compared to 28% from the US.
Conversely, seventy-two percent of US investigators included their
own genetics data compared to 8% of Chinese investigators.
Unpublished data beyond those of the investigators participating
in the meta-analysis were rarely included in any meta-analysis
(n = 1 in China-based articles, n = 0 in US-based articles). Meta-
analyses from the US tended to examine more genes than ones
from China. A majority (88%) of Chinese meta-analyses addressed
gene variants that were previously identified using a candidate-
gene approach. In comparison, US meta-analyses were evenly split
between candidate-genes and GWAS-derived genes and/or new
GWAS discoveries.
As shown in Table 5, there was a significant difference in China-
versus US-based meta-analyses in the use of fixed and/or random
effects models for data synthesis (P,0.0001), because US articles
were mostly GWAS where fixed effects analyses are long
established as the standard method applied for making discoveries.
The largest relative risks and the largest statistically significant
relative risks were not significantly different in the two groups of
meta-analyses, when all 100 meta-analyses were considered. The
largest significant risks were larger in China- rather than US-based
meta-analyses, when limited to the set that did not include GWAS-
validated genes (median 1.81 v 1.21, P=0.036). Both groups of
meta-analyses claimed significant results in the abstract (76%
versus 82% in China versus US), but genome-wide significant
findings were observed predominantly in US meta-analyses
(n = 23), with only one exception in the China group (P,0.001
for the China-US comparison). Both groups usually concluded
favorably for the presence of genetic associations (80% versus
72%). There was a suggestion that the Chinese group was more
likely to invoke ethnicity/ancestry differences (24% versus 8%,
P=0.054) and possibly also associations that are specific to an
inheritance model (8% versus 2%) in their discussion of the results,
but these differences were not nominally statistically significant.
Inclusion of Data from GWA Studies and from Chinese-
language Literature
One study from China included data from GWA studies, while
GWAS data was included in 31 of the 50 meta-analyses from the
US (P,0.001). Among the 48 studies from China and 12 from the
US that performed literature searches, the eligibility criteria aimed
to include data from published Chinese-language studies in 38
meta-analyses versus 8 respectively (P=0.448). Literature searches
perused Chinese-language biomedical literature database in 21
versus 1 meta-analyses, respectively (P=0.041). Chinese-language
studies were included in the meta-analysis calculations in 20 versus
2 meta-analyses (P,0.001 for all studies, P=0.180 for studies
using literature searches). A total of 65 Chinese-language genetic
association studies were included in the calculations of 20 China-
based meta-analyses, and 9 meta-analyses included .=3
Chinese-language studies. In contrast, a total of 9 Chinese
language genetic association studies were included in the
calculations of 2 US-based meta-analyses. Articles in languages
other than English and Chinese were considered eligible according
to the Methods section in 29 meta-analyses from China and 7
Table 4. Comparison of Characteristics of Genetic Association
Meta-analyses Published in 2012 from China and US.
Characteristic China US P value
Journal impact factor, median (IQR) 2.541 6.575 ,0.001
Number of authors 1 2 0 ,0.001
2 2 2
3–5 18 8
6–10 25 5
11–50 3 21
.50 0 14
English language 49 50 1.00
Disease/Phenotype Cancer 23 8 0.001
Cardiovascular 6 7
Infectious diseases 2 0
Other disease 14 17
Non-disease 5 18
Type of data included Literature 46 14 ,0.001
Investigators’ own 0 12
Both 4 24
Other unpublished data 1 0 1.00
Number of genes
assessed
1 44* 13 ,0.001
2 3 1
3 0 0
.3 3 36
Number of genetic
variants assessed
1 27 10 ,0.001
2 12 1
3 3 1
.3 8 38
New genes/variants
proposed
Yes 2 18 ,0.001
No 48 32
If no, proposed genes
from GWAS
None 45 16 ,0.001
Some 0 0
All 5 16
Metrics reported in the
abstract
Relative risk 43 15 ,0.001
Absolute difference 0 1
Both 0 0
None 7 34
US: United States.
*Includes a study that evaluated a single intergenic variant.
doi:10.1371/journal.pone.0065602.t004
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meta-analyses from the US among the 48 and 12 meta-analyses
respectively that performed any literature searches (P=1.00).
Discussion
Our empirical overview of the meta-analyses literature shows a
rapid increase in meta-analysis studies worldwide. The increase is
most prominently seen in China, specifically in genetics. Chinese
publication of genetic association meta-analyses was more than 5
times higher than US-published meta-analyses during 2012 and
currently China dominates the global production of papers in this
field. In the last 8 years, the annual production of meta-analyses of
China has increased 40-fold overall with a 110-fold increase in
genetics.
The vast majority of the genetics meta-analyses from China
resulted from combining data from association studies evaluating
one or two specific gene variants that had been proposed in the
candidate gene era. These studies based significant results on
nominal significance (P,0.05) rather than genome-wide signifi-
cance thresholds. US investigators tended to include their own
genetic data in the meta-analyses whereas Chinese papers typically
did not address GWAS-proposed variants. Many of the China-
based meta-analyses also include published Chinese-language
studies that are not indexed in western databases.
China is becoming an increasingly important player in
biomedical research as illustrated in the exponential contribution
of published works from Chinese investigators. To our knowledge,
the meta-analysis literature from China has not been compara-
tively evaluated previously in a systematic fashion. One exception
is an empirical evaluation of systematic reviews of acupuncture
from China. The evaluation suggested that the systematic reviews
conducted lacked rigor in appraising the risk of bias in included
studies [21]. Likewise, empirical investigations in some other fields,
including single genetic association studies of candidate genes,
clinical trials, and randomized trials on acupuncture have
suggested that Chinese studies present a prominent excess of
significant results [22–25] that requires cautious interpretation.
Strong evidence has accumulated on the low replication rates of
past candidate gene associations, when these associations are
evaluated in large-scale consortia with agnostic testing of gene
variants across the whole genome [8,9,15]. Thus, one may infer
that the large majority of significant associations proposed in meta-
analyses of candidate gene studies are likely to perpetuate false-
positive findings. Therefore, it is likely that the majority of China-
produced genetic meta-analyses are reaching false-positive con-
clusions. The reasons for this may be manifold, but we have
identified some potential explanations.
First, China-based meta-analyses do not employ data from
GWA studies. This may be due to the fact that these data are not
readily available to a wider public, or they may need approval
processes which hinder access from Chinese meta-analysts. In
some occasions, the genetic variants of interest may not be
captured by agnostic platforms, although this is not common with
Table 5. Results and Conclusions of Genetic Association Meta-analyses Published in 2012 from China and US.
All meta-analyses Not GWAS genes*
China US China US
N=50 N=50 N=45 N=16
Statistical model for synthesis** Fixed effect only 1 32 0 5
Random effects only 3 7 2 5
Both fixed and random 46 11 43 6
P value ,0.001 ,0.001
Largest relative risk in abstract Median, IQR 1.75, 1.25 1.49, 1.74 1.75, 1.26 1.21, 2.08
P value 0.86 0.078
Largest significant relative risk in abstract Median, IQR 1.81, 1.31 1.66, 1.76 1.81, 1.31 1.21, 2.08
P value 0.68 0.036
Significant results in the abstract 38 41 33 9
P value 0.62 0.22
Any GWS results in the abstract 1 23 0 0
P value ,0.001 1.00
Abstract conclusions on associations Presence of association 40 37*** 35 8
P value 0.63 0.055
Ethnicity/ancestry differences 12 4 11 3
P value 0.054 0.74
Inheritance model-specific 4 1 4 1
P value 0.36 1.00
More evidence is needed 15 9 13 6
P value 0.24 0.54
IQR: interquartile range, GWS: genome-wide significant, US: United States.
*Includes only data from meta-analyses that include only candidate genetic variants that have not been validated in GWAS **Methods combining p-values or z-scores,
or pooled analysis, were counted as equivalent to fixed effects; Mixed effects model was counted as random effects *** some studies with significant reported results
are counted here, even if no concluding statement was made.
doi:10.1371/journal.pone.0065602.t005
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current GWA platforms that have very high genome coverage and
imputation should make this concern even less important [26].
Second, China-based meta-analyses tended to focus on testing
single genes and gene variants that were proposed in the
candidate-gene era. This approach does not address genetic
variants that have emerged with far stronger statistical support
from large-scale consortia performing GWAS [27]. Overall, these
meta-analyses have not followed the evolution of human genome
epidemiology in the direction of GWA studies, e.g. currently large-
scale synopses of genetic association studies routinely try to
incorporate the GWA data, which are typically the largest datasets
in each field [28,29]. Lack of inclusion of GWA data in the current
meta-analysis literature may not be necessarily exclusive to China.
Meta-analysts from other countries may also continue to perform
candidate-gene meta-analyses. Unfortunately, the number of such
meta-analyses from other countries is extremely small compared to
China to allow a meaningful evaluation.
Third, many China-based meta-analyses performed more
exhaustive literature searches than US-based meta-analyses and
included data from Chinese-language publications that are often
indexed only in Chinese literature databases [13]. While
inclusiveness is commendable in principle, previous experience
suggests that language bias could affect the results in different ways
depending on the field involved [4,30,31]. In some disciplines, it
may be preferable to exclude rather than to include data from
specific countries. It was demonstrated [25] that there is a prolific
Chinese language literature on genetic association studies
addressing variants of the candidate gene era and this literature
might be biased towards reporting of statistically significant results
[25]. This was not due to the quality of the studies based on the
reported features of their methods and conduct [25], but may be
due to selective reporting of ‘‘positive’’ results. Under such
circumstances, inclusion of these data may propagate further
false-positive results at the meta-analysis level.
We should acknowledge some limitations in our study. We did
not assess in depth the quality of the evaluated meta-analyses,
which could further explain the differences between China and US
meta-analyses. Quality of published genetic association meta-
analyses is difficult to assess as there is no guarantee that reported
features accurately reflect real practices adopted during the
conduct of the meta-analysis [32]. As previously observed [25],
reported quality of Chinese genetic association studies was
comparable to studies performed in other countries. Moreover,
quality comparisons between China and the US might not be
meaningful or even feasible because the types of research
endeavors differ between the two countries with minimal overlap,
e.g. meta-analyses of published data on candidate gene associa-
tions versus consortium analyses of GWA data. Eventually, one
needs to assess the essential features and reliability of a meta-
analysis regardless of its country of origin. However, the extremely
rapid increase in Chinese meta-analyses of candidate gene variants
is a phenomenon that cannot be underestimated and it has no
parallel in any other country to-date.
Allowing for these caveats, our empirical evaluation documents
an extraordinary, geometric growth of the meta-analysis literature
produced by authors from China in the last few years, with strong
emphasis on genetic associations. This surge in meta-analysis
applications presents conflicting issues. On the one hand, meta-
analyses of data abstracted from the literature and from candidate-
gene studies may propagate an epidemic of false claims for
candidate gene associations. Conversely, the extraordinary scien-
tific potential of China can offer tremendous impetus to evidence-
based medicine in general and genetics more specifically, if it is
appropriately harnessed. Efforts should be made to familiarize
Chinese meta-analysts with the newer waves of genetic studies and
improved access to large-scale consortium databases and active
participation in such consortia [33] may be useful steps in this
direction. China is already a leading power in modern genomic
technologies, with unparalleled sequencing capacity and is already
assuming a leading role in the emerging omics fields [34–36].
Meta-analyses could also be facilitated to reach higher levels of
reliability.
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